Musashi-1在肝细胞肝癌中的表达及其与临床预后的关系
CSTR:
作者:
作者单位:

第二军医大学上海东方肝胆外科医院,第二军医大学上海东方肝胆外科医院,第二军医大学上海东方肝胆外科医院,第二军医大学上海东方肝胆外科医院

作者简介:

通讯作者:

中图分类号:

基金项目:

上海市优秀学科带头人计划(14XD1400100).


Expression of Musashi-1 in hepatocellular carcinoma and its relationship with clinical prognosis
Author:
Affiliation:

The Second Military Medical University Eastern Hepatobiliary hospital,Shanghai,200433,The Second Military Medical University Eastern Hepatobiliary hospital,Shanghai,200433,The Second Military Medical University Eastern Hepatobiliary hospital,Shanghai,200433,The Second Military Medical University Eastern Hepatobiliary hospital,Shanghai,200433

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 研究Musashi-1在肝细胞肝癌患者癌组织及癌旁组织中的表达,探讨其与临床预后的关系及对肝癌细胞转移侵袭的影响。方法 收集我院2000年6月至2010年6月间138例行根治性肝细胞肝癌切除术患者的术中肝癌以及癌旁样本,利用免疫组织化学方法检验癌组织与癌旁组织中Musashi-1的表达水平;通过Pearson χ2检验和Fisher精确检验分析Musashi-1与患者临床特征以及预后之间的关系。利用qPCR检测癌组织和癌旁组织中CD133的表达并对癌组织中Musashi-1与CD133的表达水平进行相关性分析。构建稳定过表达Musashi-1的人肝癌细胞系SMMC-7721细胞,利用Sphere成球实验检测Musashi-1对肿瘤细胞成球能力的影响,利用肿瘤侵袭实验探究Musashi-1对肿瘤细胞侵袭能力的影响。结果 138例肝细胞肝癌患者中有105例(76.1%)癌组织中Musashi-1的表达高于癌旁组织(P<0.05)。Musashi-1的表达与甲胎蛋白(AFP)水平、腹水、远处转移有关(P<0.05),而与性别、年龄、乙肝病史、肿瘤大小、子灶、门静脉癌栓、镜下癌栓等无关。Musashi-1的表达水平对患者总体生存率和无瘤生存率有显著影响(P<0.05)。肝癌组织中CD133 mRNA的表达高于癌旁组织(P<0.05),且CD133的表达与Musashi-1的表达呈正相关(R2=0.78,P<0.001)。体外实验证实过表达Musashi-1的SMMC-7721细胞的成球能力和侵袭能力增强。结论 Musashi-1在肝细胞肝癌中表达增加,对肝细胞肝癌的进展可能具有促进作用,其表达水平可以为判断预后提供参考。

    Abstract:

    Objective To study the expression of Musashi-1 in tumor tissues and adjacent non-tumor tissues of patients with hepatocellular carcinoma (HCC), and to explore the relationship between Musashi-1 and clinical prognosis and the effect of Musashi-1 on the metastasis and invasion of HCC cells. Methods We collected HCC tissues and adjacent non-tumor tissues from 138 patients undergoing radical resection of HCC in our hospital from June 2000 to June 2010. The expression of Musashi-1 in all tissues was detected by immunohistochemical method. The relationship between Musashi-1 expression and clinical characteristics and prognosis was analyzed by Pearson χ2 test and Fisher exact test. The expression of CD133 in HCC tissues and adjacent non-tumor tissues was detected by qPCR and the correlation between Musashi-1 and CD133 in tumor tissues was analyzed. Finally, we constructed SMMC-7721 cells with stable overexpression of Musashi-1, determined the effect of Musashi-1 on the sphere-forming potential of SMMC-7721 cells using Sphere formation assay, and detected the effect of Musashi-1 on the ability of cell invasion by tumor invasion experiment. Results Musashi-1 was highly expressed in 105 (76.1%) HCC tissues compared with the adjacent non-tumor tissues (P<0.05). The expression of Musashi-1 was related to α-fetoprotein (AFP) level, ascites and distant metastasis (all P<0.05), but not to gender, age, HBV contagious history, tumor size, tumor foci, portal vein tumor thrombus or microscopic tumor thrombus (P>0.05). Spearman analysis indicated that HCC patients with higher Musashi-1 expression have significantly worse overall survival rate (P<0.05) and disease-free survival (P<0.05) compared with those with low Musashi-1 expression. The expression of CD133 mRNA in HCC tissues was significantly higher than that in the adjacent non-tumor tissues (P<0.05), and CD133 expression was positively correlated with Musashi-1 expression (R2=0.78, P<0.001). In vitro experiments confirmed that overexpression of Musashi-1 enhanced the sphere-forming potential and invasive ability of SMMC-7721 cells. Conclusion Musashi-1 has higher expression in HCC tissues and may promote HCC progression and metastasis. High level of Musashi-1 may indicate poor prognosis, providing a reference for prognosis judgment in HCC patients.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2017-04-15
  • 最后修改日期:2017-06-29
  • 录用日期:2017-09-18
  • 在线发布日期: 2017-11-01
  • 出版日期:
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭